Navigation Links
New PLATO Sub-Analysis of CABG Patients Presented at ACC
Date:3/16/2010

ATLANTA, March 16 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced results of a new analysis of the PLATO (A Study of PLATelet Inhibition and Patient Outcomes) study which showed there were fewer deaths in patients with acute coronary syndromes (ACS) who took the investigational oral antiplatelet ticagrelor (BRILINTA™/BRILIQUE™) within seven days prior to having heart bypass surgery (coronary artery bypass graft, CABG) compared to those who took clopidogrel.(1) These data were presented today at the American College of Cardiology (ACC) meeting in Atlanta, Georgia.

"The CABG sub-analysis represents current clinical management of patients with ACS,"(1) said Dr. Claes Held, PhD, Associate Professor of Cardiology at the Uppsala Clinical Research Center and Department of Cardiology, and the sub-study's lead researcher.  "The effects of ticagrelor compared to clopidogrel showed a reduction of total mortality by 51% and CV death by 48%."(1)

This analysis included 1261 patients who were on study medication up to seven days prior to stopping study medication due to the need for urgent CABG surgery at any time after their ACS event.(1) The patients randomized to ticagrelor had a significantly lower rate of total and CV death than those randomized to clopidogrel tr
'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
2. Medco, Mayo Clinic Study Reveals Using a Simple Genetic Test Reduces Hospitalization Rates by Nearly a Third for Patients on Widely Prescribed Blood Thinner
3. Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
4. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
5. Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients
6. New Data Demonstrates Abbotts Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
7. An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
8. Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
9. Chronically Ill Patients Find Help Paying For Medicines
10. ISIS Initiates Phase 1 Clinical Trial of ISIS-SOD1Rx in Patients With ALS
11. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 23, 2014  The American Diabetes Association is ... for people with diabetes and that all people ... of statins, in keeping with recent changes to ... American College of Cardiology (ACC) and American Heart ... most recent changes to the Association,s annual revised ...
(Date:12/24/2014)... , Dec. 23, 2014  Medical Science Liaisons ... the key link between the medical device industry and ... more in the coming years as the device industry ... According to research by benchmarking firm, Best Practices, ... gain an important edge is by harnessing new technology ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "US Self-monitoring Blood Glucose Market" report to their ... This market insight focuses on the developments in ... United States . Reimbursement analysis and the effects ... for more than 73 SMBG meters have been performed, ...
Breaking Medicine Technology:New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4Role of Medical Science Liaisons Evolving in Medical Device Sector 2US Self-monitoring Blood Glucose Market 2
... Calif., Oct. 21 IRIDEX Corporation (Nasdaq: ... Modular Multi-Wavelength laser photocoagulator solution, which will be ... Ophthalmology meeting in San Francisco. , ... compete in the multi-wavelength photocoagulator market segment with ...
... PARK, Ill., Oct. 20 Abbott (NYSE: ABT ... of privately held eye care company Visiogen, expanding the ... lens (IOL) technology to address presbyopia for cataract patients. ... significant advancement in artificial lens technology. It is ...
Cached Medicine Technology:IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology 2Abbott Completes Visiogen Acquisition 2
(Date:12/25/2014)... “Every three months the trends for evening dresses ... be one of the hottest styles in the next few ... company releases 26 A-line sweetheart evening dresses, and announces the ... “We are trying our best to help a lady to ... with affordable prices, we provide discounted delivery costs to our ...
(Date:12/25/2014)... Recently, BellasDress has launched its ... dresses. BellasDress has chosen their best-selling lace wedding dresses, ... the holiday season. , Now, BellasDress.com features popular ... here at discount prices. The business hopes everyone can ... , “All our elegant products are made ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 Recently, LunaDress.co.uk has updated ... dresses and related accessories. Now, all of the models at LunaDress.co.uk ... moment a groom lifts the wedding veil can turn out to ... stunning charm. A wedding veil can always bring surprise to a ... suggestions on how to choose veils for a big day ...
(Date:12/25/2014)... 24, 2014 (HealthDay News) -- Among early stage breast ... than half of one percent will eventually develop leukemia ... reveals. The finding comes from a review of ... and 2007, and it suggests that the risk for ... experts had previously thought. "The frequency of bone ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 “ SmileStix ” ... which features the latest and coolest mobile applications on the ... expert and host of NewsWatch, conducted the app review and ... to create personal stickers. , The old saying goes, “A ... lot of words that can describe a single image, because ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... measure their peak heart rates for exercise will need to do ... A new formula based on a large study from ... rate a healthy woman should attain during exercise. It also will ... test. "Now we know for the first time ...
... new study of nearly 8,800 women with early-stage breast ... percent completed their full regimen of hormone therapy ... women were particularly likely to discontinue treatment. The findings ... behind such treatment non-compliance and also develop interventions to ...
... It,s time to ... are teaming up to reach Physical Education students by utilizing the dynamic media + digital ... weights. , ... and Austin, TX (PRWEB) June 29, 2010 -- Hyper Wear, LLC, a fitness, health and ...
... ... solutions for healthcare organizations, adds a New Vice President to head Client Services, Sandra ... (PRWEB) ... to Vice President of Client Services and Strategy. Fancher will work closely with our ...
... ... set to give insights on how to achieve female six pack abs in no ... Abs by Mike Geary may just be the book to read. If you are ... many instruction manuals, books and DVDs flooding the fitness market which do not offer ...
... ... Meer looks back to a six year success story as a national ... Germany. Furthermore since 2004 more and more requests have been received from ... get more and more shipped to the UK, USA and even Australia.,Strandkorb ...
Cached Medicine News:Health News:New formula gives first accurate peak heart rate for women 2Health News:Fewer than half of breast cancer patients adhere to hormonal therapy regimen, study finds 2Health News:Fewer than half of breast cancer patients adhere to hormonal therapy regimen, study finds 3Health News:HOPSports, Inc. Adds SandBell to Award-Winning Training System 2Health News:HOPSports, Inc. Adds SandBell to Award-Winning Training System 3Health News:MedTouch Makes Senior Staff Appointment 2Health News:Book Reveals the Truth about Six Pack Abs 2Health News:Strandkorb & Meer Going to Exceed 20% of Total Sales Volume with International Business in 2010 2Health News:Strandkorb & Meer Going to Exceed 20% of Total Sales Volume with International Business in 2010 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: